glioblastoma
In Brief This Week: Epitopoietic Research Corporation, SEngine Precision Medicine
News items for the week of July 25, 2022.
The company reported positive data from the Phase II RAGNAR study, in which Balversa showed activity across 14 different tumor types.
Break Through Cancer Awards $50M in Grants for Collaborative Projects in Ovarian, Pancreatic, Brain Cancers
The grant funding will support projects investigating why drug development efforts have stalled or failed in these three intractable cancers.Â
Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients
The firm will launch a Phase I trial of the C134 oncolytic virus MB-108 followed by the autologous 13Rα2-targeted CAR T-Cell therapy MB-101 for advanced glioblastoma.
Chimeric Partners With WuXi Advanced Therapies to Develop and Manufacture CAR T Therapies
WuXi's manufacturing, testing, and end-to-end closed-loop processing capabilities will accelerate clinical testing of two of Chimeric's CAR T-cell therapies.
Nov 19, 2020